Methylphenidate and Atomoxetine Enhance Prefrontal Function Through α2-adrenergic and Dopamine D1 Receptors

Overview

Journal J Am Acad Child Adolesc Psychiatry

Publisher Elsevier

Specialties Pediatrics
Psychiatry

Date 2010 Sep 22

PMID 20855046

Citations 105

Authors

Nao J Gamo

Min Wang

Amy F T Arnsten

Affiliations

Soon will be listed here.

Abstract

Objective: This study examined the effects of the attention-deficit/hyperactivity disorder treatments, methylphenidate (MPH) and atomoxetine (ATM), on prefrontal cortex (PFC) function in monkeys and explored the receptor mechanisms underlying enhancement of PFC function at the behavioral and cellular levels.

Method: Monkeys performed a working memory task after administration of a wide range of MPH or ATM doses. The optimal doses were challenged with the α(2)-adrenoceptor antagonist, idazoxan, or the D(1) dopamine receptor antagonist, SCH23390 (SCH). In a parallel physiology study, neurons were recorded from the dorsolateral PFC of a monkey performing a working memory task. ATM, SCH, or the α(2) antagonist, yohimbine, were applied to the neurons by iontophoresis.

Results: MPH and ATM generally produced inverted-U dose-response curves, with improvement occurring at moderate doses, but not at higher doses. The beneficial effects of these drugs were blocked by idazoxan or SCH. At the cellular level, ATM produced an inverted-U dose-response effect on memory-related firing, enhancing firing for preferred directions (increasing "signals") and decreasing firing for the nonpreferred directions (decreasing "noise"). The increase in persistent firing for the preferred direction was blocked by yohimbine, whereas the suppression of firing for the nonpreferred directions was blocked by SCH.

Conclusions: Optimal doses of MPH or ATM improved PFC cognitive function in monkeys. These enhancing effects appeared to involve indirect stimulation of α(2) adrenoceptors and D(1) dopamine receptors in the PFC. These receptor actions likely contribute to their therapeutic effects in the treatment of attention-deficit/hyperactivity disorder.

Citing Articles

Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: a comparative neuroimaging analysis.

Pan N, Ma T, Liu Y, Zhang S, Hu S, Shekara A Psychol Med. 2025; :1-15.

PMID: 39806554 PMC: 11769909. DOI: 10.1017/S003329172400285X.

Dynamic Network Connectivity: from monkeys to humans.

Arnsten A, Wang M, DEsposito M Front Hum Neurosci. 2024; 18:1353043.

PMID: 38384333 PMC: 10879414. DOI: 10.3389/fnhum.2024.1353043.

Noradrenergic regulation of cue-guided decision making and impulsivity is doubly dissociable across frontal brain regions.

Chernoff C, Hynes T, Schumacher J, Ramaiah S, Avramidis D, Mortazavi L Psychopharmacology (Berl). 2023; 241(4):767-783.

PMID: 38001266 PMC: 10927866. DOI: 10.1007/s00213-023-06508-2.

The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment.

Qu S, Zhou X, Wang Z, Wei Y, Zhou H, Zhang X Mol Psychiatry. 2023; 29(1):165-185.

PMID: 37957291 PMC: 11078728. DOI: 10.1038/s41380-023-02314-6.

An adolescent boy with kleptomania and attention-deficit hyperactivity disorder treated with methylphenidate and guanfacine: A case report.

Miyazaki K, Uchiyama M Neuropsychopharmacol Rep. 2023; 43(4):650-653.

PMID: 37921065 PMC: 10739163. DOI: 10.1002/npr2.12394.

References

Seidman L, Valera E, Makris N . Structural brain imaging of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005; 57(11):1263-72. DOI: 10.1016/j.biopsych.2004.11.019. View

Arnsten A, Paspalas C, Gamo N, Yang Y, Wang M . Dynamic Network Connectivity: A new form of neuroplasticity. Trends Cogn Sci. 2010; 14(8):365-75. PMC: 2914830. DOI: 10.1016/j.tics.2010.05.003. View

Shansky R, Rubinow K, Brennan A, Arnsten A . The effects of sex and hormonal status on restraint-stress-induced working memory impairment. Behav Brain Funct. 2006; 2:8. PMC: 1420310. DOI: 10.1186/1744-9081-2-8. View

Goldman-Rakic P . The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive. Philos Trans R Soc Lond B Biol Sci. 1996; 351(1346):1445-53. DOI: 10.1098/rstb.1996.0129. View

Turner D, Robbins T, Clark L, Aron A, Dowson J, Sahakian B . Relative lack of cognitive effects of methylphenidate in elderly male volunteers. Psychopharmacology (Berl). 2003; 168(4):455-64. DOI: 10.1007/s00213-003-1457-3. View

Goldman-Rakic P . Cellular basis of working memory. Neuron. 1995; 14(3):477-85. DOI: 10.1016/0896-6273(95)90304-6. View

Barkley R . Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull. 1997; 121(1):65-94. DOI: 10.1037/0033-2909.121.1.65. View

Dickstein S, Bannon K, Castellanos F, Milham M . The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis. J Child Psychol Psychiatry. 2006; 47(10):1051-62. DOI: 10.1111/j.1469-7610.2006.01671.x. View

Arnsten A . Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways. J Clin Psychiatry. 2006; 67 Suppl 8:7-12. View

10.

Arnsten A, Steere J, Hunt R . The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1996; 53(5):448-55. DOI: 10.1001/archpsyc.1996.01830050084013. View

11.

Tannock R, Schachar R . Methylphenidate and cognitive perseveration in hyperactive children. J Child Psychol Psychiatry. 1992; 33(7):1217-28. DOI: 10.1111/j.1469-7610.1992.tb00940.x. View

12.

Hess C, Reif A, Strobel A, Boreatti-Hummer A, Heine M, Lesch K . A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm (Vienna). 2008; 116(2):121-30. DOI: 10.1007/s00702-008-0138-0. View

13.

Berridge C, Devilbiss D, Andrzejewski M, Arnsten A, Kelley A, Schmeichel B . Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry. 2006; 60(10):1111-20. DOI: 10.1016/j.biopsych.2006.04.022. View

14.

Miller G, Yatin S, De La Garza 2nd R, Goulet M, Madras B . Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity. Brain Res Mol Brain Res. 2001; 87(1):124-43. DOI: 10.1016/s0169-328x(00)00288-6. View

15.

Robbins T, Roberts A . Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex. 2007; 17 Suppl 1:i151-60. DOI: 10.1093/cercor/bhm066. View

16.

Castellanos F, Tannock R . Neuroscience of attention-deficit/hyperactivity disorder: the search for endophenotypes. Nat Rev Neurosci. 2002; 3(8):617-28. DOI: 10.1038/nrn896. View

17.

Miller G, Madras B . Polymorphisms in the 3'-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry. 2002; 7(1):44-55. DOI: 10.1038/sj.mp.4000921. View

18.

Chamberlain S, Muller U, Blackwell A, Clark L, Robbins T, Sahakian B . Neurochemical modulation of response inhibition and probabilistic learning in humans. Science. 2006; 311(5762):861-3. PMC: 1867315. DOI: 10.1126/science.1121218. View

19.

Li B, Mei Z . Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav Neural Biol. 1994; 62(2):134-9. DOI: 10.1016/s0163-1047(05)80034-2. View

20.

Goldman-Rakic P, Brown R . Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys. Neuroscience. 1981; 6(2):177-87. DOI: 10.1016/0306-4522(81)90053-1. View